OralMedicine.com and ahVanguard to Revolutionize Oral Cancer
OralMedicine.com and ahVanguard partner to Revolutionize Oral Cancer Screening with AI. OralMedicine.com, a leading provider of oral health resources, has announced a strategic partnership with ahVanguard to integrate cutting-edge AI marketing automation and conversational chatbot technology to assist dental practices in improving oral cancer screening processes.
The new AI-powered system will work in conjunction with oral cancer screening devices like VELscope to help dentists take the next steps after identifying potential abnormalities. This collaboration aims to increase early detection rates and improve patient outcomes for oral cancer.
Why This Matters:
Oral cancer is a serious and potentially life-threatening disease that affects thousands of people each year. Early detection is crucial for successful treatment and improved survival rates. According to the Oral Cancer Foundation, when found at early stages of development, oral cancers have an 80 to 90% survival rate[1].
However, many cases are not discovered until later stages, leading to poorer outcomes. By leveraging AI technology to enhance the screening process, OralMedicine.com and ahVanguard hope to address this critical gap in oral healthcare.
Key Benefits for Dental Practices:
- Automated follow-up: The AI chatbot can immediately engage patients after a VELscope screening to provide information and next steps.
- Streamlined referrals: For suspicious findings, the system can help coordinate referrals to oral surgeons or specialists for further evaluation.
- Patient education: The conversational AI can answer common questions about oral cancer and the importance of regular screenings.
- Appointment scheduling: The chatbot can assist in booking follow-up appointments or annual screenings to ensure continuity of care.
This partnership represents a significant step forward in our mission to improve oral health outcomes. By combining ahVanguard’s healthcare marketing and AI expertise with our oral health knowledge, we can empower dental practices to detect oral cancer earlier and potentially save lives.
The new AI-enhanced oral cancer screening support system is expected to launch in select dental practices later this year, with a wider rollout planned for 2024.
For more information on how this technology can benefit your dental practice, visit OralMedicine.com or contact our partnership team.
This press release highlights the partnership, explains the importance of oral cancer screening, and outlines the key benefits of the AI system for dental practices. It provides a mix of factual information and promotional content typical of a press release format.
Citations:
[1] https://velscope.com/patient/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529297/
[3] https://www.asfamilydental.com/velscope-for-oral-cancer-screening/
[4] https://velscope.com/doctor/
[5] https://www.greentreedentalchicago.com/the-importance-of-oral-cancer-screenings/
[6] https://fastbots.ai/ai-chatbots-for-dentists
[7] https://www.gargle.com/roadmap-to-ai-powered-marketing-transforming-your-dental-practice/
[8] https://www.avadent.com/ai-is-transforming-dental-marketing-with-predictive-search-engagement/
[9] https://bestresultsdentalmarketing.com/2024/29/how-can-ai-help-with-dental-marketing/
[10] https://www.peerlogic.com/complete-guide-to-conversational-ai-and-how-its-transforming-dental/
[11] https://www.clintnewmandds.com/velscope-oral-cancer-screening/
[12] https://implantsprocentersanfrancisco.com/velscope-vx-operation-advantages-safety/
[13] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748804/
[14] https://dentalchat.com/best-dental-chatbot-marketing-online-dentist-bot-for-website-messaging